( in Million)
Particulars
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
978.4
1455.6
3947.6
9567
Total Expenditure
1679.3
1854.8
4197.8
9439.3
PBIDT (Excl OI)
-700.9
-399.2
-250.2
127.70
Other Income
153.9
118.5
130.2
46.2
Operating Profit
-547
-280.7
-120
173.9
Exceptional Items
NA
NA
-1239.7
NA
PBDT
-724.3
-351.3
-1474.7
77.49
Depreciation
157.3
155
158.3
557.4
Profit Before Tax
-881.6
-506.3
-1633
-479.9
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-694.3
-448.3
-1213.8
-369.5
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-141.5
-246.1
-1295.9
-423.7
Minority Interest
20.8
16.1
41.9
17.8
Shares of Associates
-36.7
-24.7
-56.1
0
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-157.4
-254.7
-1310.1
-405.9
Equity Capital
1116.9
1116.9
1116.9
1116.9
Face Value (IN RS)
10
10
10
10
Calculated EPS
-1.40
-2.28
-11.72
-3.63
Calculated EPS (Annualised)
-5.63
-9.12
-46.91
-14.53
No of Public Share Holdings
55616080
55616080
55617710
55617710
% of Public Share Holdings
49.79
49.79
49.79
49.79
PBIDTM% (Excl OI)
-71.63
-27.42
-6.33
1.33
PBIDTM%
-55.90
-19.28
-3.03
1.81
PBDTM%
-74.02
-24.13
-37.35
0.81
PBTM%
-90.10
-34.78
-41.36
-5.01
PATM%
-70.96
-30.79
-30.74
-3.86